P32 Sodium Phosphate
P32 Chromic Phosphate Suspension
Approved
Approval ID
4996cd1e-4338-43d7-b7aa-418909ab8c16
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 19, 2012
Manufacturers
FDA
AnazaoHealth Corporation
DUNS: 011038762
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
P32 Sodium Phosphate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code51808-127
Product Classification
G
Generic Name
P32 Sodium Phosphate
Product Specifications
Route of AdministrationINTRA-ARTICULAR, INTRAPERITONEAL, INTERSTITIAL, INTRAPLEURAL
Effective DateOctober 13, 2012
FDA Product Classification
INGREDIENTS (4)
DEXTROSEInactive
Quantity: 0.3 g in 1 mL
Code: IY9XDZ35W2
Classification: IACT
PHOSPHORUS P-32Active
Quantity: 5 mCi in 1 mL
Code: 690284A407
Classification: ACTIB
BENZYL ALCOHOLInactive
Quantity: 0.02 mL in 1 mL
Code: LKG8494WBH
Classification: IACT
SODIUM ACETATEInactive
Quantity: 1 mg in 1 mL
Code: 4550K0SC9B
Classification: IACT